ArticleInternational urology and nephrology2026
177Lu-vipivotide tetraxetan (PSMA-617) vs cabazitaxel in metastatic castration-resistant prostate cancer: a real-world analysis using the TriNetX database.
Parisa Aijaz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.